Maggie Yuen

Chief Financial Officer

Maggie joined Penumbra in 2019, serving as Chief Financial Officer. Prior to Penumbra, Maggie spent more than 20 years of progressive leadership experience driving scalable finance organizations, processes and infrastructure in the manufacturing, medical devices, and life science industries. She most recently served as Vice President of Finance of the Genetic Science Division within Thermo Fisher Scientific, Inc., a business focused on instrument platforms, cloud-based software, content and services. In her role, she directed finance operations, strategic planning and business development activities, among a number of other executive functions. Prior to Thermo Fisher, Maggie held leadership positions with increasing responsibility at Mirion Technologies, and senior finance roles at Boston Scientific, Glu Mobile, and Johnson & Johnson. Maggie has also served on the Board of Directors of AtriCure, Inc. since June 2021. She received an MAcc and MBA from the Weatherhead School of Management and a BS from Case Western Reserve University.


Contact us to learn more about our products and company